Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Thank You!

    Your message has been sent.

    Oops, message not sent.

    Please make sure fields are complete.

    News

    Holiday Wishes and New Year Resolutions


    I would like to wish everyone the best for this holiday season. May you all cherish the moments you have with your family and blessings to you all for a Healthy and Happy New Year. I thank each and every one of you for the caring and support you…

    Read Article

    Chondrosarcoma Awareness Day Tribute to Parker Jeffrey Morgan


    With Chondrosarcoma Awareness Day: February 6, less than two months away, we want to share stories of our community / our family who provide us with inspiration. Some of our members lost their battle with Chondrosarcoma. Others are surviving,…

    Read Article

    February 6 is Chondrosarcoma Awareness Day


    International Chondrosarcoma Awareness Day February 6, 2023 Wear A Yellow Ribbon / Wrist Band and Show Your Support for Chondrosarcoma Research and Clinical Trials As many of you are aware to honor my daughter who passed away from Grade 3…

    Read Article

    Poster Presentation regarding INBRX-109 at CTOS Conference on November 16-19


    Read Article

    INBRX-109 Phase 2 Clinical Trial to Treat Unresectable or Metastatic Conventional Chondrosarcoma


    Inhibrx has initiated a phase 2 clinical trial to treat unresectable or metastatic conventional chondrosarcoma. The poster was presented at the Connective Tissue Oncology Society (CTOS) in Vancouver, Canada from November 16-19. The results of the…

    Read Article

    INBRX-109 Phase 2 Study still looking for Patients


    Inhibrx is recruiting for Chondrosarcoma patients to participate in their Phase 2 study of the medication. Presently there are 130 openings for the Phase 2 trial. Summary is listed below, for more…

    Read Article

    Inhibrx Announces Participation in Upcoming Scientific Conferences on INBRX-109


    SAN DIEGO, Oct. 20, 2022 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced it will be presenting at multiple upcoming…

    Read Article

    Pictures from Steppin’ for a Cause


    Here are pictures from our event: Steppin’ for A Cause held on October 15, at Allen Pond in Bowie, Maryland. We had 50 people participate in our 5k Walk / Run and raised $3,200 ($500 more than last year). Thank you to everyone for your…

    Read Article

    Contact Information


    If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

    **A Registered 501c3 Non-Profit Charity Organization. All donations are tax-deductible.**

    Send a Message